CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-08 | Wilmslow Estates Ltd 10% owner | Option exercise · Common Stock Warrant (Right to Buy) | −11,502 | 0 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion | +9,667 | 22,985 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion | +5,871 | 28,747 | ||
| 2014-12-08 | RAKIN KEVIN Director | Option exercise | +242 | $0.76 | $184 | 28,989 |
| 2014-12-08 | RAKIN KEVIN Director | Sale | −17 | $11.00 | $187 | 28,972 |
| 2014-12-08 | RAKIN KEVIN Director | Purchase | +6,742 | $11.00 | $74K | 35,714 |
| 2014-12-08 | RAKIN KEVIN Director | Other disposition | −89 | 35,625 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion | +6,444 | 42,069 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion | +3,914 | 45,983 | ||
| 2014-12-08 | RAKIN KEVIN Director | Purchase | +4,495 | $11.00 | $49K | 50,478 |
| 2014-12-08 | RAKIN KEVIN Director | Other disposition | −58 | 50,420 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion · Series A Preferred Stock | −9,667 | 0 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion · Series A-1 Preferred Stock | −5,871 | 0 | ||
| 2014-12-08 | RAKIN KEVIN Director | Option exercise · Common Stock Warrant (Right to Buy) | −242 | 0 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion · Series A Preferred Stock | −6,444 | 0 | ||
| 2014-12-08 | RAKIN KEVIN Director | Conversion · Series A-1 Preferred Stock | −3,914 | 0 | ||
| 2014-12-08 | Lewis Michael Director | Conversion | +747,000 | 1,036,244 | ||
| 2014-12-08 | Lewis Michael Director | Conversion | +492,618 | 1,528,862 | ||
| 2014-12-08 | Lewis Michael Director | Option exercise | +11,502 | $0.76 | $9K | 1,540,364 |
| 2014-12-08 | Lewis Michael Director | Sale | −792 | $11.00 | $9K | 1,539,572 |
Page 26 of 27 · 525 trades